Series A for Coherex brings in $8.5mm
Coherex Medical (developing technologies to treat heart defects) raised $8.5mm in a private placement of Series A convertible preferred shares led by Oxford Bioscience and vSpring Capital.
- Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com